Advertisement
Advertisement

EWTX

EWTX logo

Edgewise Therapeutics, Inc. Common Stock

15.51
USD
-4.62
-22.98%
Apr 02, 15:59 UTC -4
Closed
exchange

Pre-Market

14.32

-1.20
-7.70%

Edgewise Therapeutics, Inc. Common Stock Profile

About

Edgewise Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing orally bioavailable, small molecule therapies for rare muscle disorders. Edgewise Therapeutics Inc. is based in Boulder, United States.

Info & Links

CEO

Kevin Koch

Headquarters

1715 38TH ST
BOULDER, CO 80301, UNITED STATES

Sector

Medical

Auditor

KPMG LLP

Share holders

5

Employees

110

Edgewise Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.36B

Enterprise Value

1.32B

Enterprise Value/EBITDA(ttm)

-7.82

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

5.20

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-26.83%

Return on Invested Capital(ttm)

-27.12%

Return on Assets(ttm)

-25.67%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-169.09M

Net Income Available to Common(ttm)

-133.81M

Diluted EPS(ttm)

-1.50

Share Statistics

Beta (5Y Monthly)

0.20

52-Week Change

-12.25%

S&P 500 52-Week Change

8.82%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

95.21M

Dividend Yield

0.00%

Float4

71.86M

% Held by Insiders

24.11%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

470.17M

Total Cash Per Share(mrq)

4.94

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

19.93%

Quick Ratio(mrq)

26.35%

Book Value Per Share(mrq)

4.84

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.18

Free Cash Flow(ytd)

-110.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement